TABLE 2:
Treatment parameters
| n-BCA | PVA | |
|---|---|---|
| Number of patients | 52 | 49 |
| Number of stages | 77 | 86 |
| Duration of embolization (min) | 178 | 168 |
| Duration of fluoroscopy (total min) | 93.8 | 109.6 |
| Coils used (stages) | 15 | 61* |
| Coils used (mean) | 204(14.4)** | 559(10.0)% |
| Number of patients, no coils used | 39 | 9 |
| Particle size used among procedures | ||
| <500 μm | 18(36.7%) | |
| <500 μm only, no coils | 5(10.6%) | |
| 500–710 μm | 42(29.6%) | |
| 710–1000 μm | 22(15.5%) | |
| 1000–1400 μm | 5(3.5%) | |
| Infusion catheters | ||
| 3-French infusion | 31(31.3%) | 53(52%) |
| Flow-directed catheter | 62(62.6%) | 33(32.4%) |
| Other | 6(6.1%) | 16(15.7%) |
| Guidewires | ||
| 0.018 | 0 | 5(3.8%) |
| 0.016 | 10(11.5%) | 28(21.5%) |
| 0.014 | 11(12.6%) | 34(26.2%) |
| 0.010 | 51(58.6%) | 41(31.5%) |
Note.—n-BCA indicates n-bytyl cyanoacrylate; PVA, polyvinyl alcohol.
*
P < .0001.
**
95 coils used in one patient.